- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04204135
The Course of Hip Flexion Weakness Following LLIF or ALIF
March 19, 2024 updated by: Rush University Medical Center
The purpose of this study is to assess the course of hip weakness after LLIF or ALIF procedures.
These outcomes include measures of hip strength using a dynamometer, which is a device used to measure muscle strength.
While it is known that people experience temporary hip and leg weakness after an LLIF or ALIF, the exact timing of when hip and leg strength is regained after an LLIF or ALIF is not known.
Study Overview
Status
Enrolling by invitation
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing LLIF or ALIF procedures
Description
Inclusion Criteria:
- 1-, 2-, or 3-level L2L3, L3L4, or L4L5 LLIF or ALIF for degenerative pathology including radiculopathy, neurogenic claudication, intervertebral disc disease, facet joint disease, degenerative spondylolisthesis, degenerative myelopathy degenerative kyphosis, and scoliosis
- Back and/or leg pain
- Failed at least 6 months of conservative treatment
Exclusion Criteria:
- Older than 65 years of age
- Prior spinal fusion surgery
- Greater than Grade 2 spondylolisthesis
- Greater than 10° scoliosis
- History of spinal infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hip flexion and knee extension strength as measured by the Lafayette Instrument Manual Muscle Testing Device (Dynamometer).
Time Frame: Assessing changes in hip flexion and leg extension strength from the preoperative baseline to postoperative measurements taken at 6 weeks, 12 weeks and 6 months following lumbar fusions.
|
Using a Lafayette Instrument Manual Muscle Testing Device (Dynamometer), we will be measuring the force in pounds a given patient can exert upon hip flexion and knee extension at the preoperative timepoint and 6 weeks, 12 weeks and 6 months postoperatively.
|
Assessing changes in hip flexion and leg extension strength from the preoperative baseline to postoperative measurements taken at 6 weeks, 12 weeks and 6 months following lumbar fusions.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 4, 2018
Primary Completion (Estimated)
September 4, 2025
Study Completion (Estimated)
November 4, 2025
Study Registration Dates
First Submitted
August 20, 2019
First Submitted That Met QC Criteria
December 16, 2019
First Posted (Actual)
December 18, 2019
Study Record Updates
Last Update Posted (Actual)
March 21, 2024
Last Update Submitted That Met QC Criteria
March 19, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16081205
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
-
Synergy Spine SolutionsMCRANot yet recruitingCervical Degenerative Disc DiseaseUnited Kingdom
Clinical Trials on LLIF or ALIF procedures
-
Helsinki University Central HospitalOulu University Hospital; Seinajoki Central Hospital; Central Finland Hospital...CompletedFoot Diseases | Ankle DiseaseFinland
-
Nambudripad's Allergy Research FoundationAnonymousCompleted
-
PediatrixPhoenix Children's Hospital; Banner HealthActive, not recruitingBPD - Bronchopulmonary DysplasiaUnited States
-
University of MagdeburgUniversity of ZurichCompletedSepsis | Death | Peritonitis | Multiple Organ FailureGermany
-
Gachon University Gil Oriental Medical HospitalKyunghee University Medical Center; Daejeon University; Sangji University Oriental... and other collaboratorsCompletedNervous System Diseases | Pain | Neurologic Manifestations | Back Pain | Low Back PainKorea, Republic of
-
Centre Hospitalier Universitaire de BesanconUnknown
-
National University of SingaporeUnknownStage 5 Chronic Kidney DiseaseSingapore
-
Microvention-Terumo, Inc.RecruitingCerebrovascular StrokeGermany, Switzerland
-
Kansas Joint and Spine InstituteISTO Technologies, Inc.; National Center of Innovation for Biomaterials in...UnknownDegenerative Disc DiseaseUnited States
-
Centre Cardiologique du NordUniversita degli Studi di Genova; Campus Bio-Medico University; Henri Mondor... and other collaboratorsEnrolling by invitation